Human PDAC KRAS Survival Analysis cBioPortal Kaplan-Meier

KRAS Variant Analysis & Survival Outcomes in PDAC

KRAS variant distribution and Kaplan-Meier survival analysis on 2,034 PDAC patients from MSK 2024. G12D (42.5%), G12V (33.6%), G12R (16.7%) with significant survival differences (p<0.0001) — completed in 41 seconds.

Download PDF

Can't see the report? Open the PDF directly or download it.

Run Your Own Analysis

Upload your data and describe your experiment. Pipette handles the entire pipeline.

Get Started Free